Access to medication abortions via telehealth varies by state and here s why newschannel5.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newschannel5.com Daily Mail and Mail on Sunday newspapers.
email article
The FDA will allow mifepristone (Mifeprex) to be dispensed by mail during the pandemic, temporarily lifting previous requirements that it be given to patients in person, the agency said on Monday.
In a letter to the American College of Obstetricians and Gynecologists (ACOG) and the Society for Maternal-Fetal Medicine (SMFM), acting FDA Commissioner Janet Woodcock, MD, stated that the agency will exercise enforcement discretion regarding the in-person dispensing requirement for mifepristone, as long as the president s declaration of a public health emergency for COVID-19 remains in place.
Essentially, FDA won t enforce the in-person prescribing requirement that s part of the drug s risk management program.
ANSIRH Study Shows Dispensing Medication Abortion Pills at Pharmacy is Safe, Effective, and Satisfying to Patients
Share Article
Over 90% of patients were satisfied with the pharmacy experience
“Pharmacists play a critical role in health care delivery. This study shows that they can safely and effectively dispense mifepristone, and that removing or modifying the REMS to allow for this provision would eliminate a significant barrier to care,” said Dr. Daniel Grossman. SAN FRANCISCO (PRWEB) April 08, 2021 A new study by Advancing New Standards in Reproductive Health (ANSIRH) at the University of California San Francisco (UCSF), documents the safety, efficacy, and patient satisfaction of medication abortion with mifepristone dispensed by pharmacists. As states push legislation to further restrict abortion care in clinics and hospitals, medication abortion through pharmacy dispensing could increase access where
COVID Put Remote Abortion to the Test Supporters Say It Passed medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
Conditions
Feb 24, 2021 05:31 PM By Yvonne Stolworthy Abortion, a hot-button issue around the globe, sees frequent protests on both sides of the issue. AFP / OLIVIER DOULIERY
In December, the Supreme Court reversed a lower court ruling that had allowed abortion medications to be sent by mail. Since then, women looking to terminate a pregnancy with the combination medications packet containing mifepristone and misoprostol now must go, in person, to a medical provider.
But this in-person requirement is not necessary in many states and Washington, D.C. Since March 2016, a study has been underway to follow participants who have used the drugs and to assess the drugs’ safety and tolerability. The trial’s sponsor is Gynuity Health Projects; the trial’s listed completion date on clinicaltrials.gov is June 2022. The participating states are listed here.